OBJECTIVE: Although rheumatoid arthritis (RA) has long been associated with an HLA-DRB1 shared epitope, a systematic search for other epitopes has never been conducted. In addition, the relationship between these epitopes and the binding of citrullinated autoantigens has not been investigated. We developed a program that can analyze HLA data for all possible epitopes of up to 5 amino acids and used this program to assess the shared epitope hypothesis in RA. METHODS: We analyzed high-resolution data from the International Histocompatibility Working Group, which included a group of 488 patients with RA and a group of 448 racially and ethnically balanced control subjects, for all combinations of up to 5 amino acids among polymorphic HLA-DRB1 positions 8-93. Statistical significance was determined by chi-square and Fisher's exact tests, with a false discovery rate correction. RESULTS: Three residues (V(11), H(13), and L(67)) were found to have the highest degree of association with RA susceptibility (P < 10(-11)), and D(70) was found to correlate best with RA resistance (P = 2 × 10(-11)). Of >2 million epitopes examined, LA(67, 74) exhibited the highest correlation with RA susceptibility (P = 2 × 10(-20); odds ratio 4.07 [95% confidence interval 3.07-5.39]). HLA alleles containing the LA(67, 74) epitope exhibited significantly greater binding to citrullinated vimentin(65-77) than did alleles containing D(70). Only 1 allele (DRB1*16:02) contained both LA(67, 74) and D(70); it bound citrullinated vimentin weakly and was not associated with RA. CONCLUSION: The findings of these studies confirm the importance of HLA-DRB1 amino acids in pocket 4 for the binding of citrullinated autoantigens and susceptibility to RA.
OBJECTIVE: Although rheumatoid arthritis (RA) has long been associated with an HLA-DRB1 shared epitope, a systematic search for other epitopes has never been conducted. In addition, the relationship between these epitopes and the binding of citrullinated autoantigens has not been investigated. We developed a program that can analyze HLA data for all possible epitopes of up to 5 amino acids and used this program to assess the shared epitope hypothesis in RA. METHODS: We analyzed high-resolution data from the International Histocompatibility Working Group, which included a group of 488 patients with RA and a group of 448 racially and ethnically balanced control subjects, for all combinations of up to 5 amino acids among polymorphic HLA-DRB1 positions 8-93. Statistical significance was determined by chi-square and Fisher's exact tests, with a false discovery rate correction. RESULTS: Three residues (V(11), H(13), and L(67)) were found to have the highest degree of association with RA susceptibility (P < 10(-11)), and D(70) was found to correlate best with RA resistance (P = 2 × 10(-11)). Of >2 million epitopes examined, LA(67, 74) exhibited the highest correlation with RA susceptibility (P = 2 × 10(-20); odds ratio 4.07 [95% confidence interval 3.07-5.39]). HLA alleles containing the LA(67, 74) epitope exhibited significantly greater binding to citrullinated vimentin(65-77) than did alleles containing D(70). Only 1 allele (DRB1*16:02) contained both LA(67, 74) and D(70); it bound citrullinated vimentin weakly and was not associated with RA. CONCLUSION: The findings of these studies confirm the importance of HLA-DRB1 amino acids in pocket 4 for the binding of citrullinated autoantigens and susceptibility to RA.
Authors: Luis Francisco Valdés-Corona; Susana Hernández-Doño; Tatiana Sofia Rodríguez-Reyna; Rafael García-Silva; Juan Jakez; Monica Escamilla-Tilch; Guadalupe Lima; Luis Llorente; Carlos Pineda; Edmond Yunis; Julio Granados Journal: J Transl Autoimmun Date: 2020-05-15
Authors: Christina L Roark; Kirsten M Anderson; Lucas J Simon; Ronald P Schuyler; Michael T Aubrey; Brian M Freed Journal: Diabetes Date: 2014-01 Impact factor: 9.461
Authors: Adeline Ruyssen-Witrand; Hanna W van Steenbergen; Jurgen van Heemst; Pierre-Antoine Gourraud; Delphine Nigon; Cédric Lukas; Corinne Miceli-Richard; Bénédicte Jamard; Anne Cambon-Thomsen; Alain Cantagrel; Philippe Dieudé; Annette H M van der Helm-van Mil; Arnaud Constantin Journal: RMD Open Date: 2015-11-19
Authors: Christina Gerstner; Anatoly Dubnovitsky; Charlotta Sandin; Genadiy Kozhukh; Hannes Uchtenhagen; Eddie A James; Johan Rönnelid; Anders Jimmy Ytterberg; Jennifer Pieper; Evan Reed; Karolina Tandre; Mary Rieck; Roman A Zubarev; Lars Rönnblom; Tatyana Sandalova; Jane H Buckner; Adnane Achour; Vivianne Malmström Journal: Front Immunol Date: 2016-11-14 Impact factor: 7.561
Authors: Christina Gerstner; Sara Turcinov; Aase H Hensvold; Karine Chemin; Hannes Uchtenhagen; Tamara H Ramwadhdoebe; Anatoly Dubnovitsky; Genadiy Kozhukh; Lars Rönnblom; William W Kwok; Adnane Achour; Anca I Catrina; Lisa G M van Baarsen; Vivianne Malmström Journal: BMC Immunol Date: 2020-05-18 Impact factor: 3.615
Authors: A Jabrocka-Hybel; A Skalniak; J Piątkowski; R Turek-Jabrocka; P Vyhouskaya; A Ludwig-Słomczyńska; J Machlowska; P Kapusta; M Małecki; D Pach; M Trofimiuk-Müldner; K Lizis-Kolus; A Hubalewska-Dydejczyk Journal: J Endocrinol Invest Date: 2018-06-21 Impact factor: 4.256